MQQQ yields 2.33% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MQQQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MQQQ + PFE for your $10,000?
MQQQ provides 2x leveraged exposure to the monthly performance of QQQ, an ETF composed of 100 NASADAQ-listed stocks. The strategy involves entering into one or more swap agreements intended to produce leveraged investment results relative to the returns of QQQ. Unlike traditional ETFs, MQQQ introduces added volatility due to its lack of diversification and use of leverage. Holdings are rebalanced at month-end to maintain the 200% exposure. However, if QQQs price drops by 35% or more within a month, the fund will rebalance early to protect against further losses, although this may prevent it from meeting its target return for that month. To maximize results, the fund places its remaining cash in US government securities, money market funds, short-term bond ETFs, or high-quality corporate debt as collateral. Before May 16, 2025, the fund was named Tradr 2X Long Triple Q Monthly ETF.
Full MQQQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.